| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Gwenn Hansen is Chief Scientific Officer at NRIX. From November 2020 to November 2026, the filings on record show 0 open-market purchases and 40 sales. Gwenn Hansen's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $3.2M at current prices.
Historically, Gwenn Hansen's trades have earned a strong insider score of 70/100 across 35 rated trades. Over a 12-month horizon, 78.6% of those trades were profitable, with an average 12-month return of +22.1%.
The NRIX filings lean toward selling, a net 80,920 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 30, 2025 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 4,308 | $12.01 | $51,743.39 | -5.9% | +0.2% | - | |
| Apr 30, 2025 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 3,377 | $11.50 | $38,841.24 | -5.2% | +3.1% | +44.8% | |
| Jan 30, 2025 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 3,690 | $19.85 | $73,259.85 | -6.2% | -42.4% | -17.5% | |
| Oct 30, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 3,437 | $24.31 | $83,536.29 | -6.4% | -18.7% | -46.9% | |
| Jul 30, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 3,408 | $20.67 | $70,435.52 | -7.0% | +27.3% | -42.8% | |
| Apr 30, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 2,007 | $12.04 | $24,168.70 | -4.8% | +76.8% | -4.1% | |
| Jan 30, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 2,334 | $7.99 | $18,649.13 | -6.0% | +56.1% | +145.9% | |
| Oct 31, 2023 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 1,633 | $5.20 | $8,487.35 | -4.6% | +49.7% | +330.6% | |
| Jul 31, 2023 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 1,884 | $9.65 | $18,189.45 | -5.9% | -45.8% | +113.9% | |
| May 1, 2023 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 1,136 | $9.88 | $11,219.48 | -4.1% | -1.9% | +21.4% |